HOUSTON, Nov. 6, 2007 (PRIME NEWSWIRE) -- BlueStar Health, Inc., (Pink Sheets:BLSH) announced today that the Company has initiated the process necessary for re-listing on the OTC Bulletin Board. The Company is currently up-to-date in all of its regulatory filings, and as such, meets all of the requirements set out by the Securities and Exchange Commission (SEC) and the National Association of Securities Dealers (NASD) for re-listing.
The process, which takes between 30 and 90 days from initiation, calls for the NASD to review the information package submitted by a sponsoring NASD member firm and address additional requests that may arise from the review. Once approved, listing is immediate.
BlueStar Chief Executive, Richard Greenwood, commented, "We have worked diligently with the Company's legal counsel, Auditors and sponsoring Broker Dealer to put the BlueStar in a position to re-list on the Bulletin Board. We believe this is a very important step and will make it a priority to ensure the desired outcome in a timely manner." He continued, "The re-listing will also provide the Company with higher quality access to growth capital, both debt and equity-based, than we can expect as a company listed on the OTC pink sheets. This is important of course in the context of our long-term plan to maximize share values."
About BlueStar Health
BlueStar, through its wholly-owned subsidiary, Zeon Fuel, Inc., is engaged in the business of blending purchased bio-diesel and petroleum diesel fuels and distributing the blended product through retail outlets. The company intends to expand its distribution through owned and leased facilities as well as fuel contracts with retail outlets. For more information on BlueStar's primary operating entity, Zeon Fuel, Inc., please visit www.zeonglobalenergy.com
Forward-Looking Statements
This news release includes comments that may be deemed forward-looking within the meaning of the safe harbor provisions of the U.S. Federal Securities Laws. These include, among other things, statements about expectations of future events or transactions, sales of products or performance. Forward-looking statements are subject to risks and uncertainties that may cause the company's results to differ materially from expectations. These risks include the company's ability to execute its business plan, having necessary financing in time to meet contractual obligations and support the business activity, and other such risks as the company may identify and discuss from time to time, including those risks disclosed in the company's current and future filings with the Securities and Exchange Commission. Accordingly, there is no certainty that the company's plans will be achieved.